Top

Published in:

Open Access 01-09-2020 | Contraception | Review

Postnatal Care of Woman with Rheumatic Diseases

Author: Maria Mouyis

Published in: Advances in Therapy | Issue 9/2020

Abstract

Caring for women in the postnatal period can be challenging. One of the most important aspects is ensuring disease control as there is a risk of flare in the postpartum period. Other aspects of care also need to be addressed with the mother in mind such as breastfeeding or with the neonate in mind such as vaccinations or complications of the maternal condition affecting the neonate. This article highlights aspects of care that need to be addressed in the postpartum period such as flare rates, maternal wellbeing, thromboembolism, vaccinations, contraception and breast feeding.

Østensen M, Andreoli L, Brucato A, Cetin I, Chambers C, Clowse MEB, et al. State of the art: reproduction and pregnancy in rheumatic diseases. Autoimmun Rev. 2015;14:376–86.PubMedCrossRef

Clowse MEB, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127.e1–.e6.CrossRef

De Man YA, Hazes JMW, Van Der Heide H, Willemsen SP, De Groot CJM, Steegers EAP, et al. Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study. Arthritis Rheum. 2009;60(11):3196–206.PubMedCrossRef

Ackerman IN, Jordan JE, Van Doornum S, Ricardo M, Briggs AM. Understanding the information needs of women with rheumatoid arthritis concerning pregnancy, post-natal care and early parenting: a mixed-methods study. BMC Musculoskelet Disord. 2015;16(1):1–10.CrossRef

Romano M, Cacciatore A, Giordano R, La Rosa B. Postpartum period: three distinct but continuous phases. J Prenat Med. 2010;4(2):22–5.PubMedPubMedCentral

van den Brandt S, Zbinden A, Baeten D, Villiger PM, Østensen M, Förger F. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients. Arthritis Res Ther. 2017;19(1):64.PubMedPubMedCentralCrossRef

Andreoli L, García-Fernández A, Gerardi MC, Tincani A. The course of rheumatic diseases during pregnancy. Israel Med Assoc J. 2019;21(2):464–70.

Giles I, Yee CS, Gordon C. Stratifying management of rheumatic disease for pregnancy and breastfeeding. Nat Rev Rheumatol. 2019;15(7):391–402. https://doi.org/10.1038/s41584-019-0240-8 (Epub 11 Jun 2019).PubMedCrossRef

Bobirca A, Bobirca F, Ancuta I, et al. FRI0054 risk factors for postpartum flare in rheumatoid arthritis—a romanian cohort. Ann Rheum Dis. 2018;77:574.

10.

Jethwa H, Lam S, Smith C, Giles I. Does rheumatoid arthritis really improve during pregnancy? A systematic review and meta-analysis. J Rheumatol. 2019;46(3):245–50.PubMedCrossRef

11.

Bjørngaard H, Jakobsen B, Koksvik HSS, Wallenius M. AB1302 results from the prospective nationwide norwegian pregnancy qualityregister revnatus. Ann Rheum Dis. 2018. https://doi.org/10.1136/annrheumdis-2018-eular.4549.CrossRef

12.

Mouyis MA, Thornton CC, Williams D, Giles IP. Pregnancy outcomes in patients with psoriatic arthritis. J Rheumatol. 2017;44:128–9. https://doi.org/10.3899/jrheum.160929.PubMedCrossRef

13.

Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Semin Arthritis Rheum. 2017;46:740–5. https://doi.org/10.1016/j.semarthrit.2017.01.002.PubMedCrossRef

14.

Berman M, Paran D, Zisman D, Wollman J, Levartovsky D, Elkayam O. AB0776 the effect of pregnancy on disease activity outcomes in psoriatic arthritis patients. Ann Rheu Dis. 2017. https://doi.org/10.3899/jrheum.171218.CrossRef

15.

Ursin K, Lydersen S, Skomsvoll JF, Wallenius M. Disease activity of juvenile idiopathic arthritis during and after pregnancy: a prospective multicenter study. J Rheumatol. 2018;45:257–65.PubMedCrossRef

16.

Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016;75(5):795–810.PubMedCrossRef

17.

Brambell FW. The transmission of immunity from mother to young and the catabolism of immunoglobulins. Lancet. 1966;2(7473):1087–93.PubMedCrossRef

18.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids | Rheumatology | Oxford Academic [Internet]. 2020. https://academic.oup.com/rheumatology/article/55/9/1693/1744535.

19.

Flint J, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—part II: analgesics and other drugs used in rheumatology practice. Rheumatology. 2016;55:1698–702.PubMedCrossRef

20.

Julsgaard M, Christensen LA, Gibson PR, et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology. 2016;151(1):110–9. https://doi.org/10.1053/j.gastro.2016.04.002.PubMedCrossRef

21.

Health England P. Age due diseases protected against vaccine given and trade name usual site. 2020.

22.

Abstract Number: 1896. Breastfeeding in women with rheumatic diseases. Naira Ikram, Amanda Eudy and Megan Clowse, Duke University, DurhamMeeting: 2019 ACR/ARP Annual Meeting.

23.

Newton ER. Lactation and breastfeeding. In: Gabbe SG, Nielby JR, Simpson JL, et al., editors. Obstetrics: normal and problem pregnancies. 7th ed. Philadelphia: Sanders (Elsevier); 2017. pp. 517–48.

24.

Bermas BL. Lactation and management of postpartum disease, vol. 43. Rheumatic Disease Clinics of North America: W.B. Saunders; 2017. pp. 249–62.

25.

Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529–56.PubMedCrossRef

26.

Puchner A, Gröchenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, et al. Immunosuppressives and biologics during pregnancy and lactation: a consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation. Wien Klin Wochenschr. 2019;131(1–2):29–44.PubMedPubMedCentralCrossRef

27.

Venous thromboembolic risk in postpartum - Servier - PhlebolymphologyServier – Phlebolymphology [Internet]. 2020. https://www.phlebolymphology.org/venous-thromboembolic-risk-in-postpartum/.

28.

Knight M. Saving lives, improving mothers’ care maternal, newborn and infant clinical outcome review programme. 2019.

29.

Nelson-Piercy C. Handbook of obstetric medicine. 2015.

30.

Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium–a register based case-control study. Am J Obstet Gynecol. 2008;198(233):e1–e7.

31.

Morris JM, Algert CS, Roberts CL. Incidence and risk factors for pulmonary embolism in the postpartum period. J Thromb Haemost. 2010;8:998–1003.PubMed

32.

Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost. 2008;6(6):905–12.PubMedCrossRef

33.

James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194:1311–5.PubMedCrossRef

34.

Thrombosis and embolism during pregnancy and the puerperium, reducing the risk (Green-top Guideline No. 37a) [Internet]. 2020. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg37a/.

35.

Sammaritano LR. Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 2014;23(12):1242–5.PubMedCrossRef

36.

A-Z fact sheets | The Royal Women’s Hospital [Internet]. 2020. https://www.thewomens.org.au/health-information/fact-sheets#improving-your-recovery-after-birth-physiotherapy-advice.

37.

Mørkved S, Bø K. Effect of postpartum pelvic floor muscle training in prevention and treatment of urinary incontinence: a one-year follow up. BJOG An Int J Obstet Gynaecol. 2000;107(8):1022–8.CrossRef

38.

Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther. 2020;22(1):52.PubMedPubMedCentralCrossRef

39.

Lateef A, Petri M. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2013;27:435–47.PubMedCrossRef

40.

Cauldwell M, Nelson-Piercy C. Maternal and fetal complications of systemic lupus erythematosus. Obstet Gynaecol. 2012;14(3):167–74.

41.

Clowse MEB. Lupus activity in pregnancy. Rheum Dis Clin N Am. 2007;33:237–52.CrossRef

42.

Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun. 2018;93:16–23.PubMedCrossRef

43.

Lazzaroni MG, Dall’Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, et al. A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun. 2016;74:106–17.PubMedCrossRef

Title: Postnatal Care of Woman with Rheumatic Diseases
Author: Maria Mouyis
Publication date: 01-09-2020
Publisher: Springer Healthcare
Keywords: Contraception
Systemic Lupus Erythematosus
Vaccination
Care
Pre-Eclampsia
Published in: Advances in Therapy / Issue 9/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI: https://doi.org/10.1007/s12325-020-01448-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Postnatal Care of Woman with Rheumatic Diseases

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2020

The Burden of Pain Associated with Osteoarthritis in the Hip or Knee from the Patient’s Perspective: A Multinational Cross-Sectional Study

Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review

A Comparison of Analgesia After a Thoracoscopic Lung Cancer Operation with a Sustained Epidural Block and a Sustained Paravertebral Block: A Randomized Controlled Study

Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics, and Safety Study

Global Quality Standard for Identification and Management of Severe Asthma

Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page